Organisation

Organisation name

NPOJORTC
Japanese Organisation for Research and Treatment of Cancer

The director general

The Chair

Dr. Satoru Iwase, MD, PhD.
Professor, Department of Palliative Care, Saitama Medicine University

Location/Contact

Address：302,2-54-6,Nishinippori,Arakawa-ku,Tokyo,JAPAN
TEL：03-5604-9850　FAX：03-5604-9851　E-mail：info@jortc.jp

Organisation Chart

Aim

JORTC aims for the establishment of standard cancer treatment and its propagation which lead to the promotion for health, medical, and welfare systems. JORTC undertakes affairs to support physicians and researchers in conducting clinical trials, including support for protocol-writing, data management and statistical consideration to maintain and guarantee the quality of clinical trials, and organizing and operating a third-party supervisory /management system to give a-priori assessment of protocols as well as to monitor and evaluate the progress, safety, and efficacy of clinical research. JORTC fulfills its tasks efficiently, intensively, and constantly and makes knowledge acquired through the operation open to the public.

Our main activities

（１）Providing support for protocol-writing related to cancer research and treatment
（２）Data management and statistical consideration to maintain / guarantee the quality of clinical trials related to cancer research and treatment
（３）Organizing and operating a third-party supervisory /management system to give a-priori　assessment of protocols as well as to monitor and evaluate progress, safety, and efficacy of clinical trials related to cancer research and treatment
（４）Providing information about clinical trials related to cancer research and treatment

Steering Committee

The Chair

Dr. Satoru Iwase, MD, PhD.
Professor, Department of Palliative Care, Saitama Medicine University

Data Center

The Chair

Dr. Akira Inoue, MD, PhD.
Professor, Department of Palliative Medicine, Tohoku University School of Medicine

Advisory Board Members

In June 2021, Dr. Masashi Kato (National Cancer Center Japan) passed away. We are deeply sorry to hear that. He was a great person who supported us for many years. May he rest in peace.

■Advisory Board Member

Non Profit organization JORTC established the Advisory Board to evaluate the activities by the use of third party.

  • JORTC advisory board members are as follows;
  • Dr. Yoshiyuki Kizawa, MD,PhD,FJSIM, DSBPMJ, Professor and Chair, Department of Palliative and Supportive Care, Institute of Medicine, University of Tsukuba
  • Dr. Mitsunori Miyashita, RN, PHN, PhD, Professor, Department of Palliative Nursing, Health Sciences, Graduate School of Medicine, Tohoku University
  • Dr. Yasuhito Uezono, MD, PhD, Professor, Department of Pain Control Research, The Jikei University School of Medicine
  • Dr. Eduardo Bruera, MD, FT McGraw Chair in the Treatment of Cancer, Chair, Department of Palliative, Rehabilitation, & Integrative Medicine, UT MD Anderson Cancer Center
  • Dr. David Currow, B Med, MPH, FRACP Professor, Discipline of Palliative and Supportive Services, Flinders University Flinders Centre for Clinical Change, Flinders University Chief Investigator, PaCCSC (Palliative Care Clinical Studies Collaborative)

■Protocol Review Committee / Independent data monitoring committee

【Protocol Review Committee】
・reviews and evaluates the concept of study.
・approves the initiation of clinical research through reviewing the submitted protocol.

【Independent data monitoring committee】
・monitors the progress, safety, and efficacy of clinical studies throughout trials.
・reviews the adverse event reports.
・recommends the termination of the research or the protocol revision when it is necessary.
・reviews the revised protocol and approves it.

  • ●The chair
  • Dr. Yasushi Goto, MD., Department of Respiratory Medicine, National Cancer Center Hospital
  • ●The vice-chair
  • Dr. Teruhisa Azuma, MD., Director, Department of General Medicine, Nara Prefecture General Medical Center
  • Dr. Hiroto Ishiki, MD., Department of Palliative Medicine, National Cancer Center Hospital
  • ●The members
  • Dr. Aya Kuchiba, PhD., Associate Professor, School of Health Innovation, Kanagawa University of Human Services
  • Dr. Nobuhiko Seki, MD, PhD., Clinical Professor, Division of Medical Oncology, Department of Internal Medicine, Teikyo University School of Medicine
  • Dr. Masataka Taguri, PhD., Professor, Department of Health Data Science, Tokyo Medical University
  • Ms. Ayano Takeuchi, Associate Professor, Department of Integrated Science and Engineering for Sustainable Societies, Chuo University
  • Ms. Makiko Mieno, MSc., Associate Professor, Information Center, Jichi Medical University
  • Dr. Mitsunori Miyashita, RN, PHN, PhD., Professor, Department of Palliative Nursing, Tohoku University
  • Dr. Masanori Mori, MD., Director, Division of Palliative and Supportive Care/Palliative Care Team, Seirei Mikatahara General Hospital
  • Mr. Tetsuya Wako, Pharmacist., Department of Pharmacy, Nippon Medical School Hospital

■Audit Committee

  • ●The chair
  • Dr. Takayasu Kurata, MD, PhD, Professor, Department of Thoracic Oncology, Kansai Medical University Hospital
  • ●The members
  • Dr. Terufumi Kato, MD, Department of Thoracic Oncology, Kanagawa Cancer Center
  • Dr. Hirotsugu Kenmotsu, MD, PhD, Division of Thoracic Oncology, Shizuoka Cancer Center
  • Dr. Yoshihisa Matsumoto, MD, PhD, Department Director, Department of Palliative Therapy, Cancer Institute Hospital of Japanese Foundation for Cancer Research

■Conflict of interest committee

  • ●The members
  • Dr. Aya Kuchiba, PhD., Associate Professor, School of Health Innovation, Kanagawa University of Human Services



Published：2012.12.13
Last updated：2024.09.19